TOKYO, Nov. 14, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM") announces that today, PRISM a...
Abstract Released for E7386, Co-Developed Through Collaborative Research Between Eisai and PRISM T...
Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combi...
PRISM BioLab will utilize PepMetics®, innovative small molecules that mimic three-dimensional struc...
Eli Lilly and Company, Santec Holdings Corporation participated in the round TOKYO, Jan. 24, 2024 ...
* Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) target...
TOKYO, Jan. 4, 2022 /PRNewswire/ -- PRISM BioLab, a Japan based biotechnology company with a propri...